Publications
Specialty
Search
Cath Lab Digest, CardioVascular
08/31/2024
The patient is a 77-year-old man with diabetes mellitus, congestive heart failure, and abdominal aortic aneurysm status post repair with stent graft placement, who has been suffering from bilateral foot wounds that have been nonhealing. The wounds have been present for more than six months.
EMSWorld
08/30/2024
We must learn from the fire service and lean on our senior members to coach and lead newer team members.
EMSWorld
08/30/2024
Not every poison is in a pill. In this case of One Pill Can Kill, we’ll explore a toxin that in tiny amounts can be deadly in infants.
EMSWorld
08/30/2024
Mercy Flights and Jackson County Fire District 1 have joined forces to equip both ground and air ambulances with ultrasound machines, enhancing emergency medical services.
Cath Lab Digest, CardioVascular, Journal of Invasive Cardiology
08/30/2024
The borderzone has been a fascinating yet understudied area of the infarcted heart. It is where surviving heart muscle cells attempt to stabilize and even proliferate after being disconnected from their dying neighbor cells. The newly reported findings suggest that limiting mechanical stress at the borderzone, inhibiting DNA sensing, and preventing type I IFN signaling may represent new opportunities for patients to avoid development of heart failure after MI.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
It had been thought that new arteries form their unique characteristics, such as length and diameter, based purely on mechanical cues, such as the velocity of the fluid flowing through them. However, “this study shows that pre-arterial cells already have characteristics of arteries before any fluid flows through them,” Dr. Elena Cano says.
EP Lab Digest
08/30/2024
AF prevalence expected to double in coming decades – new ESC Guidelines focus on tackling comorbidities, education for patients and families, and shared decision making
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
A new study published in Nature Medicine and carried out by researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) resolves a critical debate by establishing clonal hematopoiesis as a new risk factor for atherosclerosis.
Cath Lab Digest, CardioVascular, Journal of Invasive Cardiology
08/30/2024
Medtronic News
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
In the STOP-or-NOT trial, discontinuation of a renin-angiotensin system inhibitor (RASI) before non-cardiac surgery resulted in a similar rate of major post-operative complications compared with RASI continuation.
EP Lab Digest
08/30/2024
Bayer Press Release
EP Lab Digest
08/30/2024
Alnylam Pharmaceuticals Press Release
CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM).
EP Lab Digest
08/30/2024
CE mark of these next-generation cardiac imaging systems will further enable connected care along the cardiology patient journey and provide clinicians with the tools to deliver more efficient and timely care
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
Peripheral arterial and aortic diseases (PAAD) is estimated to affect around 113 million people aged 40 and over globally. "The aorta and peripheral arteries are integral components of the same arterial system. Disorders in one part of this system often have implications for the other,” notes Professor Lucia Mazzolai.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
The ABYSS trial suggests that long-term beta-blocker therapy is recommended after an MI, even in the absence of heart failure, arrhythmia or uncontrolled hypertension.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
“The new guidelines prompt cardiologists to rethink chronic coronary syndromes as caused not only by blockages in large arteries but also by dysfunction of smaller vessels (microcirculation),” explains Guidelines co-chair Professor Christiaan Vrints.
EMSWorld
08/30/2024
'Just Say No' is sadly not always enough. Get a glimpse into the future as it pertains to keeping our pediatric patients safe.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, EP Lab Digest
08/30/2024
Whereas prior guidelines generally recommended patients be treated to a BP
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
“This Consensus Statement aims to raise awareness on obesity as a major risk factor and provide guidance for implementing evidence-based practices for its prevention and optimal management within the context of primary and secondary CVD prevention,” says Professor Eva Prescott.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
08/30/2024
In the study, treatment with vutrisiran substantially reduced the risk of death and cardiovascular events relative to placebo.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
